Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. ANIK
ANIK logo

ANIK News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

ANIK News

GE HealthCare and Anika Executives Increase Stock Holdings

May 01 2026NASDAQ.COM

TELA Bio Announces Board Refreshment Plan for Growth

Apr 30 2026Globenewswire

Anika Therapeutics Q1 2026 Earnings Call Insights

Apr 29 2026seekingalpha

Anika Therapeutics Q1 Earnings Beat Expectations with Strong Revenue Growth

Apr 29 2026seekingalpha

Anika Therapeutics Q1 Earnings Announcement Scheduled

Apr 28 2026seekingalpha

Xilio Therapeutics Appoints New Board Member

Apr 16 2026Globenewswire

Xilio Therapeutics Appoints Cheryl R. Blanchard to Board

Apr 16 2026Newsfilter

Telix Pharmaceuticals Appoints New Non-Executive Directors

Apr 08 2026Globenewswire

ANIK Events

04/29 09:10
Company Q1 Revenue Grows to $29.6M
Reports Q1 revenue $29.6M vs. $26.2M last year. Reports total company revenue grew 13%, driven by commercial channel strength and favorable OEM channel order timing. "Our strategic transformation and organizational realignment is yielding results and driving improved profitability and efficiencies throughout the organization," said CEO Steve Griffin.
02/26 07:30
Anika Provides 2026 Guidance of $114M to $122.5M Revenue
Anika is providing the following 2026 guidance: Total Company Revenue between $114 and $122.5 million, up 1% to 9% year over year; Commercial Channel, $53 to $58 million, maintaining up 10% to 20% year over year; OEM Channel, $61 to $64.5 million, maintaining flat to modestly lower year over year; Adjusted EBITDA as a percent of revenue to 5% to 10%, reflecting higher revenues and reduced expenses offset by modestly lower U.S. pricing dynamics.

ANIK Monitor News

No data

No data

ANIK Earnings Analysis

No Data

No Data

People Also Watch